ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1504

Increased Risk of Thromboembolism Among Patients with VTE Association with Rheumatoid Arthritis

Howard Amital1,2 and Arnon-Dov Cohen3, 1Department of Medicine B, Center for Autoimmune Diseases, Sheba Medical Center, Tel-hashomer, Israel, 2Department of Internal Medicine 'D', Sackler Faculty of Medicine, Tel-Aviv University, Kfar-Saba, Israel, 3Chief Physician's Office, Clalit Health Services, Tel Aviv, Israel

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: Inflammation, pulmonary complications, rheumatoid arthritis (RA) and thrombosis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 9, 2015

Title: Rheumatoid Arthritis - Clinical Aspects Poster II

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Increased
risk of thromboembolism among patients with VTE association with Rheumatoid
Arthritis

 

 Background/Purpose: Rheumatoid arthritis (RA), is among most
common autoimmune conditions manifested by progressive and irreversible joint destruction.
Less is known about its hematological aspects.

The aim of this
study was to assess whether an association exists between RA and venous
thromboembolism (VTE); pulmonary embolism and/or deep vein thrombosis.

Methods: This study was a cross-sectional
analysis
performed
utilizing the database of Clalit Health
Services, the largest healthcare provider
organization in Israel. All patients diagnosed with RA [‘cases’] were compared
with age and sex matched controls that did not have RA (by a ratio of 1:5).
Data on health-related lifestyles and other comorbidities were collected.
χ2, t-tests, and logistic regression models were used to
compare the study groups
.

Results: This study included 11,782 patients with RA, in all ages, compared
to 57,973 controls, which were age, Sex, BMI and socioeconomic statue matched.
The prevalence of VTE in people with RA was increased by a factor of 2.2 (CI
2.03-2.42)

 in comparison to
control group in each category (P< 0.001). This factor contributed more than
a history of smoking, increased BMI or older age (Table 1).

Conclusion: Our results significantly demonstrate that RA is associated with
increased rates of VTE. Pathogenic mechanisms explaining this association
should be explored.  

Table 1

O.R.

p-value

95% C.I.

Lower

Upper

 

Sex (M:F)

0.76

<0.001

.681

.849

Age

1.04

<0.001

1.036

1.043

SES

0.98

<0.02

.959

.995

RA

2.22

<0.001

2.028

2.424

Smoking

1.06

0.25

.962

1.161

BMI

1.04

<0.001

1.037

1.050

OR- Odd’s
ratio, CI – confidence interval, SES- Socioeconomical status,

RA – rheumatoid
arthritis, BMI – Body mass index


Disclosure: H. Amital, None; A. D. Cohen, None.

To cite this abstract in AMA style:

Amital H, Cohen AD. Increased Risk of Thromboembolism Among Patients with VTE Association with Rheumatoid Arthritis [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/increased-risk-of-thromboembolism-among-patients-with-vte-association-with-rheumatoid-arthritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/increased-risk-of-thromboembolism-among-patients-with-vte-association-with-rheumatoid-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology